Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proposal for Establishment of a UK Post-marketing Surveillance Registry to Study the Effectiveness, Safety and Prescribing Habits of Tocilizumab for the Treatment of Giant Cell Arteritis in the UK National Health Service, Nested Within the Existing Structure of the UK GCA Consortium and UKIVAS Studies

NCT04049071 is registered in ClinicalTrials.gov with University of Leeds as lead sponsor.

NCT NCT04049071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04049071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proposal for Establishment of a UK Post-marketing Surveillance Registry to Study the Effectiveness, Safety and Prescribing Habits of Tocilizumab for the Treatment of Giant Cell Arteritis in the UK National Health Service, Nested Within the Existing Structure of the UK GCA Consortium and UKIVAS Studies
Lead sponsor
University of Leeds
Phase
Observational
Overall status
Terminated
Start date
May 13, 2019
Completion date
June 30, 2020
Enrollment
80 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

giant cell arteritis